00:00As we know that garlic lessons have been used in our everyday life and have been used in our everyday
00:08life.
00:10So, in regards to garlic lessons, there are many compounds in it.
00:17We extract these compounds from anti-cancer activities and check it out.
00:25We have tested the MCF7 breast cancer, which is basically breast cancer.
00:34We tested them and tested them.
00:38We have tested them and tested them.
00:39This is the basic research that we have done.
00:42What did you get to this?
00:45What did you get to this?
00:47We have seen that the medicine of breast cancer is used in our breast cancer.
00:54We have seen some non-targeted effects.
00:59But our cell lines, which we have made,
01:04We have taken the organo-suffer compounds.
01:07They are more effective.
01:10And it affects our normal cells.
01:13Compared to our conventional anti-spiritics and drugs.
01:18Because it is lipid and organic.
01:21That is why our non-targeted cells have no harmful effects.
01:26So, there are harmful effects.
01:27Look, the lessons are very good.
01:29You all know that.
01:31But in the lessons, there are some things that are not absorbed in the body.
01:36And they don't have any benefits.
01:38So, in this case, it was our purpose.
01:40It is important that we have to take the first knowledge of our first knowledge.
01:44And we have to see which compound is very good.
01:47Especially, we have targeted anti-canceless compound.
01:51We have found three compounds.
01:53But one compound is di-allyl sulfide.
01:55Which we have mentioned in lessons.
01:58But it is not absorbed in our body.
02:00We have isolated that compound.
02:02And lipid base.
02:04We have also made a nanoparticle.
02:06Nanoparticles are very small, small.
02:08And we have loaded this di-allyl sulfide.
02:11Now, what is happened?
02:13It is targeted to cancer cell lines.
02:16The most important result is that we have tested it.
02:19We have tested it in Act-Trek Mumbai.
02:22We have found it.
02:22So, we have found that the breast cancer cell lines are very easy and very difficult.
02:29And the second thing is that we ensure that we can use antibiotic,
02:32When we add another compound,
02:35We also have to use cell cells.
02:37But the highest cell cell can be delivered and targeted cell to be performed.
02:41So, we have found that this anti-canceless compound is made possible.
02:48Now, we have made it to publish it to the current stage.
02:53But we have found some similar data for this.
02:55which we are also sending it to a patent.
02:58It's a good job.
02:59Our Manish Kumar Maharaj Ji has done this job.
03:02And we are going to test it in the next stage,
03:07so that this is a product level.
